Skip to main content
IRONWOOD PHARMACEUTICALS INC logo

IRONWOOD PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · IRWD ISIN · US46333X1081 LEI · 549300PC8MR6QHH6P296 US Manufacturing
Filings indexed 1,334 across all filing types
Latest filing 2026-03-19 Major Shareholding Noti…
Country US United States of America
Listing US IRWD

About IRONWOOD PHARMACEUTICALS INC

https://www.ironwoodpharma.com/

Ironwood Pharmaceuticals is a gastrointestinal (GI)-focused healthcare company dedicated to advancing the treatment of GI diseases and redefining the standard of care for patients. The company's core activities involve the development and commercialization of innovative therapies that target GI conditions. Its primary commercial product, LINZESS® (linaclotide), is a prescription medication for adults with irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). Leveraging its singular focus and deep expertise in the GI field, Ironwood Pharmaceuticals also maintains a pipeline of potential new treatments to address significant unmet patient needs.

Recent filings

Filing Released Lang Actions
SCHEDULE 13D/A - IRONWOOD PHARMACEUTICALS INC (0001446847) (Subject)
Major Shareholding Notification
2026-03-19 English
4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Issuer)
Director's Dealing
2026-03-18 English
10-K - IRONWOOD PHARMACEUTICALS INC (0001446847) (Filer)
Annual Report FY 2025
2026-02-26 English
4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Filer)
Director's Dealing
2026-02-25 English
4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Filer)
Director's Dealing
2026-02-25 English
4 - IRONWOOD PHARMACEUTICALS INC (0001446847) (Filer)
Director's Dealing
2026-02-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.